Caracterización clínica de pacientes pediátricos con tumores cerebrales primarios en un hospital de Bogotá entre 2007-2014


Autoria(s): Carrasco de los Rios, Monica Maritza
Contribuinte(s)

Ozaeta, Daniel

Galindo Ángel, Andrés Felipe

Data(s)

21/11/2016

Resumo

Introducción: En la población pediátrica los tumores cerebrales son la segunda causa de cáncer, la dificultad en su identificación produce tardanza en su diagnóstico y pocos estudios de caracterización han sido realizados en Colombia. Se realizó un estudio para identificar las características en el curso de la enfermedad. Materiales y Métodos: Estudio observacional, descriptivo, de corte transversal con pacientes pediátricos con tumores cerebrales primarios en la clínica infantil Colsubsidio entre 2007-2014. Se revisaron sistemáticamente las historias clínicas de niños con este diagnóstico en patología y posteriormente se desarrolló un análisis univariado de estos. Resultados: 56 niños fueron incluidos, encontrando que el número de consultas previas al diagnóstico fueron más de 4 con un promedio de tiempo entre la evolución de los síntomas y el diagnóstico de 161,1 días. Para la clasificación de la OMS los más frecuentes fueron los embrionarios y astrocíticos, entre estos el meduloblastoma es el más común por histología (14,29%), 50% de los pacientes presentaron remisión y 29,41% fallecieron. Discusión: Los tumores cerebrales primarios son una patología frecuente y con alta morbimortalidad. Este estudio mostró datos epidemiológicos y clínicos similares a la literatura respecto al sexo, edad, tipo de tumor y amplios rangos de tiempo en la evolución de síntomas lo que muestra la naturaleza variable de la enfermedad; se evidencia el diagnóstico tardío en pacientes reconsultantes por el mismo síntoma lo que es frecuente en estos pacientes al igual que en otros estudios nacionales.

Backround: In the pediatric population, the brain neoplasms are the second leading cause of cancer in this group, the difficulty in identifying their causes delay the diagnosis and its characterization, just a few studies have been conducted in Colombia. This study aims to identify the characteristics in the course of the disease. Materials and Methods: A observational, descriptive, cross-sectional study in pediatric patients with primary brain tumors in children's clinical Colsubsidio during 2007-2014 was performed. The medical records of children with patology diagnosis of central nervous system neoplasms were systematically reviewed; subsequently was developed a univariate analysis of this. Results: A total of 56 children were included, the number of consultations prior to diagnosis were more than 4, the average time between the onset of symptoms until diagnosis was 161.1 days. Using the WHO classification the most frequent neoplasms were the embryonic and astrocytic tumors, the medulloblastoma is the most frequent tumor by histology with a frequency of 14.29%. 50% of patients had remission and 29.41% died. Discussion: The brain neoplasms are a frequent pathology with high morbidity and mortality. This study showed epidemiological and clinical data similar to the literature about the sex, age, type of tumor and wide ranges of time of symptoms evolution, which shows the variable nature of the disease, it is evident the late diagnosis in patients reconsulting by same sintom that is common in this study and in other national studies.

Formato

application/pdf

Identificador

http://repository.urosario.edu.co/handle/10336/12736

Idioma(s)

spa

Publicador

Facultad de medicina

Direitos

info:eu-repo/semantics/openAccess

Fonte

instname:Universidad del Rosario

reponame:Repositorio Institucional EdocUR

Ezzat S, Kamal M, El-Khateeb N, El-Beltagy M, Taha H, Refaat A, et al. Pediatric brain tumors in a low/middle income country: does it differ from that in developed world? J Neurooncol. 2016;126(2):371-6.

Heuer GG, Jackson EM, Magge SN, Storm PB. Surgical management of pediatric brain tumors. Expert Rev Anticancer Ther. 2007;7(12):61-8.

Kieran MW, Walker D, Frappaz D, Prados M. Brain tumors: from childhood through adolescence into adulthood. J Clin Oncol. 2010;28(32):4783-9.

Levy AS. Brain tumors in children: evaluation and management. Curr Probl Pediatr Adolesc Health Care. 2005;35(6):230-45.

Fruhwald MC, Rutkowski S. Tumors of the central nervous system in children and adolescents. Dtsch Arztebl Int. 2011;108(22):390-7.

Wilne SH, Dineen RA, Dommett RM, Chu TP, Walker DA. Identifying brain tumours in children and young adults. Bmj. 2013;347(4):5844.

Paul SP, Debono R, Walker D. Clinical update: recognising brain tumours early in children. Community Pract. 2013;86(4):42-5.

Wilne S, Collier J, Kennedy C, Koller K, Grundy R, Walker D. Presentation of childhood CNS tumours: a systematic review and meta-analysis. Lancet oncol. 2007;8(8):685-95.

Fleming AJ, Chi SN. Brain tumors in children. Curr Probl Pediatr Adolesc Health Care. 2012;42(4):80-103.

Villarejo F MJ. Tumores cerebrales en niños. Pediatr Integral 2012;XVI(6):475- 86.

Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL. Epidemiology of brain tumors. Neurol Clin. 2007;25(4):867-90.

Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL. Epidemiology of brain tumors. Neurol Clin. 2007;25(4):867-90.

Kong KA, Khang YH, Cha ES, Moon EK, Lee YH, Lee WJ. Childhood cancer mortality and socioeconomic position in South Korea: a national population-based birth cohort study. Cancer Causes Control. 2010;21(10):1559-67.

Gerber NU, von Hoff K, von Bueren AO, Treulieb W, Deinlein F, Benesch M, et al. A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma. Eur J Cancer. 2012;48(13):2028-36.

Johnson AR, DeMatt E, Salorio CF. Predictors of outcome following acquired brain injury in children. Dev Disabil Res Rev. 2009;15(2):124-32.

Hoven EI, Lannering B, Gustafsson G, Boman KK. Persistent impact of illness on families of adult survivors of childhood central nervous system tumors: a population-based cohort study. Psychooncology. 2013;22(1):160-7.

Fischer C, Petriccione M, Donzelli M, Pottenger E. Improving Care in Pediatric Neuro-oncology Patients: An Overview of the Unique Needs of Children With Brain Tumors. J Child Neurol. 2016;31(4):488-505.

Paldino MJ, Faerber EN, Poussaint TY. Imaging tumors of the pediatric central nervous system. Radiol Clin North Am. 2011;49(4):589-616.

Ryzhova MV, Zheludkova OG, Kumirova EV, Shishkina LV, Panina TN, Gorelyshev SK, et al. [Characteristics of medulloblastoma in children under age of three years]. Zh Vopr Neirokhir Im N N Burdenko. 2013;77(1):3-10.

Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97-109.

Ullrich NJ. Neurocutaneous Syndromes and Brain Tumors. J Child Neurol. 2015.

Losa V GA, Navas P, Zamora M. Detección precoz de cáncer en Atención Primaria. Pediatr Integral. 2012;XVI(6):441-52.

Larouche V, Huang A, Bartels U, Bouffet E. Tumors of the central nervous system in the first year of life. Pediatr Blood Cancer. 2007;49(7):1074-82.

Ansell P, Johnston T, Simpson J, Crouch S, Roman E, Picton S. Brain tumor signs and symptoms: analysis of primary health care records from the UKCCS. Pediatrics. 2010;125(1):112-9.

Schmidt-Hansen M, Berendse S, Hamilton W. Symptomatic diagnosis of cancer of the brain and central nervous system in primary care: a systematic review. Fam Pract. 2015;32(6):618-23.

Khatua S, Sadighi ZS, Pearlman ML, Bochare S, Vats TS. Brain tumors in children- -current therapies and newer directions. Indian J Pediatr. 2012;79(7):922-7.

Kalifa C, Grill J. The therapy of infantile malignant brain tumors: current status? J Neurooncol. 2005;75(3):279-85.

Bouffet E. Common brain tumours in children: diagnosis and treatment. Paediatr Drugs. 2000;2(1):57-66.

Clark AJ, Sughrue ME, Ivan ME, Aranda D, Rutkowski MJ, Kane AJ, et al. Factors influencing overall survival rates for patients with pineocytoma. J Neurooncol. 2010;100(2):255-60.

Karremann M, Pietsch T, Janssen G, Kramm CM, Wolff JE. Anaplastic ganglioglioma in children. J Neurooncol. 2009;92(2):157-63.

Phi JH, Wang KC, Park SH, Kim IH, Kim IO, Park KD, et al. Pediatric infratentorial ependymoma: prognostic significance of anaplastic histology. J Neurooncol. 2012;106(3):619-26.

Ignacio G, Alvaro R. Tumores intracraneanos en niños menores de 14 años entre 1980-1990 Tesis. Medellin: Universidad de Antioquia. Facultad de medicina;1992.

Charter G, Aristizabal G, Artistizabal J, Roa C, Alvarado H. Caracterı́sticas demográficas y patológicas de los tumores del sistema nervioso central estudiados en la clı́nica El Bosque. Acta Neurol Colomb 2011;27(2):106-13.

Ramos-Clason E, Tuñon-Pitalua M, Rivas-Muñoz F, Veloza-Cabrera L. Tumores primarios del sistema nervioso central en Cartagena, 2001- 2006. Rev salud pública 2010;12 (2):257-67.

Hayashi N, Kidokoro H, Miyajima Y, Fukazawa T, Natsume J, Kubota T, et al. How do the clinical features of brain tumours in childhood progress before diagnosis? Brain Dev. 2010;32(8):636-41.

Fajardo-Gutiérrez A, González-Miranda G. Cáncer en niños residentes del Distrito Federal. 2011; 49(1):71-81.

Lyratzopoulos G, Neal RD, Barbiere JM, Rubin GP, Abel GA. Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England. Lancet Oncol. 2012;13(4):353-65.

Suarez A, Castellanos M, Simbaqueba A, Gamboa O. Aspectos clı́nicos y demora para el diagnóstico en niños con tumores del sistema nervioso central en el Instituto Nacional de Cancerologı́a de Colombia. Rev Colomb cancerol. 2011; 15(3):127- 34.

Reulecke BC, Erker CG, Fiedler BJ, Niederstadt TU, Kurlemann G. Brain tumors in children: initial symptoms and their influence on the time span between symptom onset and diagnosis. J Child Neurol. 2008;23(2):178-83.

Neervoort FW, Van Ouwerkerk WJ, Folkersma H, Kaspers GJ, Vandertop WP. Surgical morbidity and mortality of pediatric brain tumors: a single center audit. Childs Nerv Syst. 2010;26(11):1583-92.

Ning MS, Perkins SM, Dewees T, Shinohara ET. Evidence of high mortality in long term survivors of childhood medulloblastoma. J Neurooncol. 2015;122(2):321-7.

Perkins SM, Fei W, Mitra N, Shinohara ET. Late causes of death in children treated for CNS malignancies. J Neurooncol. 2013;115(1):79-85.

Rincon C. Caracterización de episodios de neutropenia febril en niños con cáncer en la Fundación Hospital de la Misericordia Tesis. Bogotá: Universidad Nacional de Colombia. Facultad de Medicina; 2013.

Ramanauskiene E, Labanauskas L, Verkauskiene R, Sileikiene R. Early development of endocrine and metabolic consequences after treatment of central nervous system tumors in children. Medicina (Kaunas). 2014;50(5):275-80.

Sanchez Gonzalez C, Andrades Toledo M, Cardeno Morales A, Gutierrez Carrasco I, Ramirez Villar GL, Perez Hurtado JM, et al. Early endocrine complications in childhood cancer survivors. Med Clin (Barc). 2016;147(8):329-333.

Institito Nacional de salud (sede Web). Bogotá: Instituto Nacional de salud; 2014 (Acceso 10 de Noviembre de 2016). Protocolos. Disponible en: www.ins.gov.co/lineas-deaccion/ Subdireccion-Vigilancia/sivigila/Paginas/protocolos.aspx.

TEME

Palavras-Chave #Tumores en niños #618.92994 #Neoplasmas en niños -- Casos clínicos #Neoplacias -- Cerebro -- Estudio de caso #Brain neoplasms #Central nervous system neoplasms #Prognosis #Mortality #Survival
Tipo

info:eu-repo/semantics/bachelorThesis

info:eu-repo/semantics/acceptedVersion